FDA grants full approval to new Alzheimer’s drug ...Middle East

The Food and Drug Administration on Thursday granted full approval to Eisai’s and Biogen’s Alzheimer’s drug Leqembi, or lecanemab, marking the first drug in the class to receive the designation. Nationally, Alzheimer’s disease affects an estimated 6.7 million people aged 65 and older. Black people are twice as likely to develop dementia than white people, and […] The post FDA grants full approval to new Alzheimer’s drug appeared first on Roll Call.

Hence then, the article about fda grants full approval to new alzheimer s drug was published today ( Friday 07/07/2023 - 01:04 AM ) and is available on Roll Call ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA grants full approval to new Alzheimer’s drug )

Also on site :

• Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
• Golfer Masashi ‘Jumbo’ Ozaki dies at 78
• Russell Brand Prays on Instagram After New Charges of Rape and Sexual Assault